Showing results (101-110 of 6,005) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|November 18, 2011
Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signalingBokyung Sung, Babatunde Oyajobi, Bharat B Aggarwal
Molecular Cancer Therapeutics|November 18, 2011
In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signalingKaren A Nolan, Mark S Dunstan, Mary C Caraher, et al.
Molecular Cancer Therapeutics|April 18, 2012
XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cellsJennifer L Allensworth, Katherine M Aird, Amy J Aldrich, et al.
Molecular Cancer Therapeutics|May 8, 2012
Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancerGeoffrey W Krystal, Erin Alesi, James L Tatum
Molecular Cancer Therapeutics|May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cellsAmir Avan, Francesco Crea, Elisa Paolicchi, et al.
Molecular Cancer Therapeutics|May 20, 2016
Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 AccumulationM Luz Flores, Carolina Castilla, Jessica Gasca, et al.
Molecular Cancer Therapeutics|May 20, 2016
The Effect of F877L and T878A Mutations on Androgen Receptor Response to EnzalutamideStefan Prekovic, Martin E van Royen, Arnout R D Voet, et al.
Molecular Cancer Therapeutics|May 20, 2016
Src as a Therapeutic Target in Biliary Tract CancerAh-Rong Nam, Ji-Won Kim, Ji Eun Park, et al.
Molecular Cancer Therapeutics|May 20, 2016
Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdAYanting Zhang, Rena G Lapidus, Peiyan Liu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa SignalsLe Tao, Jianxin Qiu, Ming Jiang, et al.
Pageof 601